Literature DB >> 11134265

P-glycoprotein-mediated drug secretion in mouse proximal tubule perfused in vitro.

Shuichi Tsuruoka1, Koh-Ichi Sugimoto1, Akio Fujimura1, Masashi Imai2, Yasushi Asano3, Shigeaki Muto3.   

Abstract

To examine the functional significance of drug-transporting P-glycoprotein (P-gp), studies were conducted in the isolated and perfused proximal tubule S2 segment from mice disrupting both mdr1a and mdr1b genes [mdr1a/1b(-)(-)] and their wild-type mice. Efflux of the intracellular fluorescence of rhodamine 123, a fluorescence substrate of P-gp, into the lumen was measured, and the decay half-time of the intracellular fluorescence (T(1/2)) as an index of the drug-transporting P-gp activity was regarded. In the wild-type mice, the T(1/2) was 34 +/- 4 s (n = 36) at the basal period and was increased to 434 +/- 41 s by the addition of luminal verapamil, a P-gp inhibitor. In the mdr1a/1b(-)(-) mice, the T(1/2) was 407 +/- 16 s (n = 10) at the basal period and was no longer affected by the luminal addition of verapamil. The digoxin content in the kidney after a repeated administration of the drug was markedly elevated in the mdr1a/1b(-)(-) mice. In conclusion, P-gp-mediated drug efflux capacity indeed exists in the apical membrane of proximal tubule cells from the wild-type mice, whereas it is absent in that of the mdr1a/1b(-)(-) mice.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11134265     DOI: 10.1681/ASN.V121177

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  7 in total

Review 1.  Measurement of renal function during drug development.

Authors:  D Craig Brater
Journal:  Br J Clin Pharmacol       Date:  2002-07       Impact factor: 4.335

Review 2.  Evaluation of in vivo P-glycoprotein phenotyping probes: a need for validation.

Authors:  Joseph D Ma; Shirley M Tsunoda; Joseph S Bertino; Meghana Trivedi; Keola K Beale; Anne N Nafziger
Journal:  Clin Pharmacokinet       Date:  2010-04       Impact factor: 6.447

Review 3.  Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part II.

Authors:  Christine E Staatz; Lucy K Goodman; Susan E Tett
Journal:  Clin Pharmacokinet       Date:  2010-04       Impact factor: 6.447

Review 4.  Endocrine and metabolic regulation of renal drug transporters.

Authors:  Lindsay L Yacovino; Lauren M Aleksunes
Journal:  J Biochem Mol Toxicol       Date:  2012-08-29       Impact factor: 3.642

5.  Downregulation of mdr1a expression in the brain and liver during CNS inflammation alters the in vivo disposition of digoxin.

Authors:  Kerry B Goralski; Georgy Hartmann; Micheline Piquette-Miller; Kenneth W Renton
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

6.  ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal.

Authors:  Cheol-Hee Choi
Journal:  Cancer Cell Int       Date:  2005-10-04       Impact factor: 5.722

Review 7.  New Insights into the Treatment of Glomerular Diseases: When Mechanisms Become Vivid.

Authors:  Da-Wei Lin; Cheng-Chih Chang; Yung-Chien Hsu; Chun-Liang Lin
Journal:  Int J Mol Sci       Date:  2022-03-24       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.